What is LB Bohle?
LB Bohle is a distinguished provider of advanced machinery and process technologies specifically engineered for the pharmaceutical solids production industry. Their extensive product portfolio encompasses cutting-edge granulation systems, precision grinding and sieving machines, and sophisticated tablet coating and handling solutions. Beyond equipment, the company offers robust technical support and dedicated research and development services, emphasizing continuous manufacturing systems to deliver efficiency and tailored solutions for their clientele. With a global footprint and a steadfast commitment to safety and resource-efficient production, LB Bohle empowers pharmaceutical firms to achieve superior quality in their manufacturing operations.
How much funding has LB Bohle raised?
LB Bohle has raised a total of $522K across 2 funding rounds:
Debt
$150K
Debt
$372K
Debt (2020): $150K with participation from PPP
Debt (2021): $372K led by PPP
Key Investors in LB Bohle
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for LB Bohle?
The substantial enterprise-level funding and strategic investment received by LB Bohle position the company for significant expansion and innovation. This capital injection is expected to fuel advancements in their continuous manufacturing technologies and broaden their global market reach. Future endeavors will likely focus on enhancing their R&D capabilities, potentially exploring new applications for their machinery, and solidifying their role as a key technology partner for pharmaceutical companies worldwide. The company's trajectory suggests a continued emphasis on delivering high-quality, safe, and resource-optimizing production solutions.
See full LB Bohle company page
